Establishing a novel strategy to tackle Huntington's disease

Through an international joint research effort involving ProQR Therapeutics of the Netherlands, Université Grenoble Alpes of France, and KTH Royal Institute of Technology of Sweden, Professor Ji-Soon Song’s research team in the Department of Biological Sciences and KAIST Institute for BioCentury of KAIST, established a novel strategy to treat Huntington’s disease. The new work showed that the protein converted from disease form to its disease-free form maintains its original function, providing new ways to approach Huntington’s disease.

This post was originally published on this site

Lawyers Lookup -